Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma

Blood. 2021 Feb 25;137(8):1124-1129. doi: 10.1182/blood.2020007994.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Lenalidomide / therapeutic use*
  • Lymphoma, Follicular / drug therapy*
  • Male
  • Middle Aged
  • Rituximab / therapeutic use*
  • Survival Analysis

Substances

  • Antineoplastic Agents
  • Rituximab
  • Lenalidomide